These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 66549)

  • 1. Serum-25-hydroxycholecalciferol and renal osteodystrophy.
    Nielsen HE; Melsen F; Lund B; Sorensen OH; Christensen MS
    Lancet; 1977 Apr; 1(8014):754-5. PubMed ID: 66549
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum 25-hydroxycholecalciferol in uremia.
    Offermann G; von Herrath D; Schaefer K
    Nephron; 1974; 13(4):269-77. PubMed ID: 4608520
    [No Abstract]   [Full Text] [Related]  

  • 3. Controversies in renal osteodystrophy.
    Maschio G
    Int J Artif Organs; 1979 Sep; 2(5):229-31. PubMed ID: 478677
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin D and analogues in renal bone disease and implications for osteoporosis.
    Kanis JA; McCloskey EV; Beneton MN
    Osteoporos Int; 1997; 7 Suppl 3():S179-83. PubMed ID: 9536328
    [No Abstract]   [Full Text] [Related]  

  • 5. How important is phosphate in the pathogenesis of renal osteodystrophy?
    Slatopolsky E; Rutherford WE; Hruska K; Martin K; Klahr S
    Arch Intern Med; 1978 May; 138 Spec No():848-52. PubMed ID: 646572
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum concentrations of 24,25-dihydroxy vitamin D in different degrees of chronic renal failure.
    Weisman Y; Eisenberg Z; Leib L; Harell A; Shasha SM; Edelstein S
    Br Med J; 1980 Sep; 281(6242):712-3. PubMed ID: 7427411
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormonal aspects of vitamin D metabolism and its clinical implications.
    Avioli LV
    Clin Endocrinol Metab; 1979 Nov; 8(3):547-77. PubMed ID: 389491
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency.
    Mawer EB; Taylor CM; Backhouse J; Lumb GA; Stanbury SW
    Lancet; 1973 Mar; 1(7804):626-8. PubMed ID: 4121843
    [No Abstract]   [Full Text] [Related]  

  • 9. [K/DOQI clinical practice guidelines for management of renal osteodystrophy in predialysis patients].
    Okada N; Tsubakihara Y
    Clin Calcium; 2004 May; 14(5):698-706. PubMed ID: 15577030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal osteodystrophy--more than a mere bone disease].
    Saha H
    Duodecim; 2001; 117(21):2181-7. PubMed ID: 12184205
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolic bone disease in chronic hemodialysis patient. Renal osteodystrophy].
    Kurihara S; Kawabe M
    Nihon Ika Daigaku Zasshi; 1987 Oct; 54(5):563-7. PubMed ID: 3693526
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vitamin D deficiency/insufficiency in patients with chronic kidney disease stage 3 and 4 -- current concept and its therapeutic strategy].
    Ishimura E; Tsuchida T
    Clin Calcium; 2004 May; 14(5):764-9. PubMed ID: 15577040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parathormone, calcitonin, 25-hydroxycalciferol and bone histology in patients with chronic renal insufficiency].
    Kokot F; Kuska J; Sledziński Z; Białas B; Luciak M
    Z Gesamte Inn Med; 1979 Nov; 34(22):665-70. PubMed ID: 549299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The course of osteodystrophy in patients with chronic kidney failure on hemodialysis].
    Zemchenko AIu; Shostka GD
    Urol Nefrol (Mosk); 1993; (6):51-4. PubMed ID: 8160326
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical picture, diagnosis and therapy of renal osteodystrophy].
    Bombor H
    Z Urol Nephrol; 1977 Aug; 70(8):603-7. PubMed ID: 335702
    [No Abstract]   [Full Text] [Related]  

  • 16. [Renal osteodystrophy in children with chronic renal insufficiency].
    Furková K; Sasinka M; Kaiserová E; Suchánek A
    Cesk Pediatr; 1986 Sep; 41(9):514-8. PubMed ID: 3769023
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal osteodystrophy.
    Bardin T
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):114S-118S. PubMed ID: 9273952
    [No Abstract]   [Full Text] [Related]  

  • 18. 1,25 (OH)2 vitamin D3 deficiency and renal osteodystrophy: should its well-accepted pathogenetic role in secondary hyperparathyroidism lead to its systematic preventive therapeutic use?
    Fournier A; Moriniere P; Boudaillez B; Renaud H; Marie A; Westeel PF; Hocine C; Belbrik S
    Nephrol Dial Transplant; 1987; 2(6):498-503. PubMed ID: 3126450
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal osteodystrophy.
    Nephrol Nurse; 1979; 1(5):44-8. PubMed ID: 261215
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of 1 alpha-(OH)D3 on renal osteodystrophy--a 5-year retrospective evaluation].
    Kakuhara T; Mizoguchi M; Itoh M; Nagasawa M; Mori T; Ohtsuka K; Kubota M; Minatoguchi T; Ohara K; Yoshida M; Koide H; Ohno J
    Nihon Jinzo Gakkai Shi; 1982 Jun; 24(6):693-704. PubMed ID: 7176180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.